Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 21, 2026 07:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease

Agios provides update on Phase 2 trial of tebapivat in sickle cell disease
May 29, 2026 07:00 ET | Source: Agios Pharmaceuticals, Inc.

Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes

Agios provides update on Phase 2b trial of tebapivat in lower-risk myelodysplastic syndromes